Report Overview
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman\'s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
This research report gives detailed data about the major factors influencing the growth of the Intrauterine Contraceptive Devices (IUCD) market at the national and local level forecast of the market size, in terms of value, market share by region, and segment; regional market positions; segment and country opportunities for growth; Key company profiles, SWOT, product portfolio and growth strategies. It studies the market\'s essential sides such as top participants, expansion strategies, business models, and other market features to improve market insight.
The report forecast global Intrauterine Contraceptive Devices (IUCD) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intrauterine Contraceptive Devices (IUCD) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
First, this report covers the present status and the future prospects of the global Intrauterine Contraceptive Devices (IUCD) market for 2015-2027.
Market Segmentation
The Intrauterine Contraceptive Devices (IUCD) market is segmented on the basis of type, application, end-use industry, and region & country.
Key Companies
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
At the same time, we classify Intrauterine Contraceptive Devices (IUCD) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
Non-hormonal
Hormonal
Inert
Market by Application
T Shapes
V Shapes
Others
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Intrauterine Contraceptive Devices (IUCD) market for the forecast period 2021 - 2027?
• What are the driving forces in the Intrauterine Contraceptive Devices (IUCD) market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Intrauterine Contraceptive Devices (IUCD) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.